Skip to search formSkip to main contentSkip to account menu

Nafronyl

Known as: 2-(Diethylamino)Ethyl Tetrahydro-Alpha-(1-Naphthylmethyl)-2-Furanpropionate, Naftidrofuryl, 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester 
A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1997
Review
1997
ZusammenfassungUnter der Fragestellung, ob sich beim Hörsturz ein Zusammenhang zwischen Hörverlustform und Prognose erkennen läßt… 
1986
1986
The relative bioavailability of the vasodilator naftidrofuryl from formulations containing its oxalate or citrate salt has been… 
1985
1985
Muscular glycolytic fuels, intermediates and end-products (glycogen, glucose, glucose-6-phosphate, pyruvate, lactate), Krebs… 
1984
1984
Increasing life expectancy increases diseases of old age. Dementia is a highly age-related brain disease in which the metabolic… 
1981
1981
Specific, sensitive, reversed-phase high-pressure liquid chromatographic assays of nafronyl (I) and its acidic metabolite and… 
1977
1977
The effects of twelve substances on local cerebral blood flow (LCBF) were studied in the normocapnic and hypercapnic conscious… 
1972
1972
SmmaryA double-blind cross-over clinical trial of naftidrofuryl (‘Praxilene,’) is described in a group of 24 elderly subjects…